The first UK patients have been enrolled on a trial for the treatment of high blood pressure at Eastbourne DGH.
Three patients have undergone the procedure by consultant cardiologists Dr Neil Sulke and Dr Steve Furniss.
Each procedure took less than an hour to perform.
Dr Steve Furniss said, “It was a straightforward procedure on a patient with very difficult to control blood pressure.
“The patient showed significant improvement in blood pressure right after the procedure that we’ll be anxious to monitor over the coming weeks and months.”
Follow up of the first two patients to use monitor shows excellent blood pressure control continue continues, without any adverse effects.
Dr Neil Sulke said “We like the fact that the procedure is reversible and that it can treat patients who are not candidates or don’t respond to the alternative technique which alters the nerve supply to the kidney and this new device treatment option could therefore be very important for treating patients with high blood pressure.”
This technology, called ROX flow coupler is a minimally invasive procedure. A small tube called a catheter is used to place the small coupler between the artery and vein in the upper leg to alter the blood flow. The procedure has an immediate effect and is fully reversible.
Dr Sulke said, “The ROX procedure holds the promise of a meaningful long-term reduction of high blood pressure in patients and may be combined with other anti-hypertension therapies.”
ROX CEO Rodney Brenneman added, “We are honoured and excited to have the highly respected team of cardiologists at Eastbourne involved in the study.”
Patients with difficult to control high blood pressure who are interested in being part of the trial should call Dr Furniss on 01323 438220, Dr Sulke 01323 435869 or Dr Sveeta Badiani on 01323 417400 bleep 0438.